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Anti-Keratin Antibodies In Human Sera: Naturally Occurring or Induced? 
T o the Edito r: 
T he report by Iwatsuki and colleagues [1] o n the specifi cty o f 
antiepidermal antibodies to keratins suggested it might be useful 
to note briefl y our o bservations of antikeratin antibodies (AKA) 
a nd their immunoflu o rescent (IF) staining pattern s, and to assess 
the clinica l signifi cance of AKA . 
Epidermal cytoplasmi c antibodies reactive w ith the basal cells 
(B -Cyt- Abs) of m ouse and rat esophagus were initially observed 
by indirect IF in the sera of 13 of27 (48% ) acute and convalescent 
b urn patients at titers o f 1 : 10-1 :40 [2]. The IF staining pattern o f 
these antibodies were as illustrated by Iwatsuki and colleagues [1] 
in their Fig 1D . Subsequent studies, including human skin as a 
s ubstrate, and a review of the frequency of B-Cyt-Abs, disclosed 
an incidence of ll % (22 of207) [3] . The possible pathognom onic 
s ignifi cance o fB-C yt-Abs, o ther than that considered by lwatsuki 
e t al [1] , has been considered in brief in an ea rlier communication 
to the J ournal [4]. as well as in detail elsewhere [3]. 
O ur o ther initial observa tio n of AK A, in this case to AKA 
referred to as the granular type (the o ther types bein g laminar 
and diffuse) [5], ca me during the stud y o f the specific ity of an-
tiepithelial antibodies in the sera o f patients with benign prostatic 
hypertrophy (B PH) and prostate cancer (PCa) [6]. In a subsequent 
fo llow- up study o f patients w ith prostatic disease, AKA of the 
la min ar type (which appear similar to that of the IF staining 
pattern identifi ed in Fig I B by Iwatsuki et al [1] as bein g reactive 
wi th the upper layer (U-Cyt» have been seen in 7 o f 42 (17% ) 
BPH patients at titers from 1 :10-1 :40 and in 6 (25% ) PCa patients 
at tiers fro m 1 :10-1 :160 [7] . 
As review ed by Iwa tsuki et al [1] , AKA occur under a variety 
of clinical circumstances, including even in "normal" individuals, 
and as such are certainly no t pathognom onic. H owever, the pos-
s ible commo nality o f origin and/or cross-reactivity of AKA w ith 
kera tin-like p ro teins o f eptihelial cells, as suggested [1] , in addition 
to o ther explanations for thei r presence [2,3,6], rem ains to be 
del ineated . 
In the interim , it perhaps would behoove us to no te that based 
on the ea rlier reports by Young et al [8] and Y ouinou et al [9], 
high titers o f A KA have hereto fore m ainly been thoug ht of: (1) 
as bein g res tricted to patients with conn ecti ve tissue disease, prin-
cipally rheumatoid arthritis, and (2) as a means to differentiate 
rheumato id arthritis from o ther diseases o f connective tissue or-
ig in . H owever, the observations by Iwatsuki et al [1] , together 
with those o f our ea rlier and recent studies, suggest that as the 
occurrence of AKA is mu ch m ore common than previously 
thought, their clinical signi fica nce, particularly w ith respect to 
connective tissue disease, m ay require reevaluation . It may be 
noted , however, that the presence of AKA m ay be a caveat in 
view o f the ea rlier suggested association between pros tatitis and 
R ei ter's syndro me, anklosing spond ylitis, and uveitis [ to]. 
Ri chard J. Ablin , Ph. D . 
Immunology Unit, Department o f Urology 
SUNY Stony Brook 
Stony Brook, N ew York 
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We are pleased that R . J. Ablin confirms our dem onstrations on 
antikeratin antibodies (AKA) in human sera. 
It is now clearl y established that AKA occur as natural anti-
bodies in m ost anim al and human sera as reported by several 
authors and very recentl y by Serre et al [1]. Such antibo dies with 
high titers are detectable by indirect immuno flu orescence in var-
ious pathologic conditions, mainly in rheum ato id arth ritis. 
H ow ever these fi ndin gs raise m any questions: We m ay suppose 
that AKA m ay be induced by the liberation of autoantigenic 
material no rmall y hidden to the immune system by its intracel-
lular loca tio n, as recently suggested by G rubauer et al [2]; how-
ever, the precise role of AKA in su(:h conditions is unknown. It 
has been suggested that IgG antikeratin intermediate fi lam ents 
m ay serve as opsonins to enhance the phagocytosis of keratin 
aggregates after cell death by m onocytes and poly m o rphonuclear 
celJs [2]. However the fun ction o f AKA Ig M , either to rem ove 
dam aged cellular co mponents or to playa role in self- to leran ce 
by acting as blocking antibodies, is no t yet well established . It is 
also possible that AKA could arise in vivo from polyclonal lym-
phocyte activation as shown by in vitro studies. The produ ction 
of anti-intermediate fil ament antibodies by hum an B ly mphocytes 
(either with the hybrido m a technology o r by the transform ation 
ofB cells using Epstein-Barr virus) [3,4] m ay represen t a common 
feature o f the norm al B-cell repertoire of the host. In autoimmune 
diseases the hypo thesis that AKA might be the consequence of 
the immune system dys fun ctions rem ains to be dem onstrated . 
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Use of the Term "Corneocyte" 
To the Editor: 
I'd like to kno w what you think about the in creas in g usc of th c 
term "corneocyte" by some derm atologists in identifyin g cells o f 
the stratum CO rn eum. The medi cal dict ionaries confine th e usc of 
the root "corneo-" exclusively to the ocular co rnea and w hen 
used as a m od ifier in a complex no un all of th e m ea nin gs refer 
to the eye o r th e cornea. 
Geo rge F. Odland , M.D. 
Schoo l of Medi ci ne 
Uni versity of Washin gto ll 
Seattle, Washin gton 
Cyclosporin A and Epidernul Cell Growth 
To the Editor: 
W e read with intcres t the article written b y Kato and colleag ues 
[1] reportin g the absence of inhibition of the keratinocy te prolif-
eration by cyclosporin A at therapeuti c levcls . Their data , ob-
tained from pi g skin in vitro, are consonant with o ur observat io ns 
m ade in humans [2] . Since that report, we now have 4 more cases 
in w hich tritiated thymidine autoradiog raph y was app lied to skin 
biopsies taken from paticnts treated w ith cycl ospo rin A for acutc 
g raft- versus-host reaction. The proportion of basa l epidermal ce lls 
synthesizin g DNA may reach 25% in these patients. Such un-
usually high labeling indexes arc in fact arguments suggcs ting 
that cyclosporin A ma y not be regard ed as an inhibitor of pro-
liferation for hum an ep iderm al ce ll s. 
C. Picrard- Franchimont , M .D. 
G. E. Pi erard, M .D. , Ph .D . 
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Acco rdin g to l3bkiston 's Gould M edica l Diction ary, cornc-, cor-
neo- is defined as "3 combi ning form meaning (a) ({) YIl e lllll , COr-
/lC DII S; (b) (Omcn , ((lnl cn I. " Corneum is defmed in the same dIC-
tio nary as "stratum corneum ." 111 
I perso nall y do not usc the wo rd "corneocy te "; but, I believe 
since it is listed, at least so me dictionarics cond o ne It . 
H owa rd P. Baden, M.D . 
H arva rd Medi ca l School 
M assach usetts Genera l H ospital 
Boston, M assachusett 
REF ERE N CE 
I. Genn aro Arc Nora AH. Nora jJ , Stander rtw. Weiss L (cds): Blak-
istoll 's Gould Medica l Dictionary. 4rh cd. New York, McG ra\\"-
Hill , 1979, pp 318-319 
2. AI Rusro l1l K, l'i ~ rard-Frall chim o l1C C, Pierard GE: Presentation ci-
niquc et histologiqlle de la maladic dll grcffo n contre I'h6tc tra itel' 
par Cyclospo rine A. Derlllatologica 171 :65-71, 1985 
)(EPLY 
We wish to th ank Dr. C. Picrard-Franchim o nt and Dr. G. E . 
Pi erard fo r their co mm ents concerni ng the effect of cy closporin 
A o n human epide rmal basal cdls in patients with graft- versu -
host disease. Their findin g that, despite the ad ministration C?f 
cyclospo rin A , epiderm:d cells s till ex pressed in creased mItOtlC 
activ ity ce rtain ly supports o ur finding that epidermal cells In PI" 
skin in vitro were not suppressed b y cyclospo rin A. 
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